Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1983]

New data in the diagnosis and prognosis of multiple myeloma

Prof Paul Richardson, Prof Phillippe Moreau, Prof Jesus San Miguel, Prof Gareth...

New data in the diagnosis and prognosis of multiple myeloma ( Prof Paul Richardson, Prof Phillippe Moreau, Prof Jesus San Miguel, Prof Gareth Morgan )

Expert Panel: Anaemia, neutropenia, thrombocytopenia and cancer

Prof Matti Aapro, Prof Mario Dicato, Prof Pere Gascón, Prof Heinz Ludwig

Expert Panel: Anaemia, neutropenia, thrombocytopenia and cancer ( Prof Matti Aapro, Prof Mario Dicato, Prof Pere Gascón, Prof Heinz Ludwig )

Recent advances in multiple myeloma, featuring Educational Updates from ASH 2012

Professor Gareth Morgan, Prof Roman Hajek, Dr María-Victoria Mateos, Prof...

Recent advances in multiple myeloma, featuring Educational Updates from ASH 2012 ( Professor Gareth Morgan, Prof Roman Hajek, Dr María-Victoria Mateos, Prof Hartmut Goldschmidt )

Clofarabine and other novel agents in AML; interview with Alan Burnett at ASH...

Prof Alan Burnett - Head of Haematology Department of Medical Genetics, Cardiff...

Clofarabine and other novel agents in AML; interview with Alan Burnett at ASH 2012 ( Prof Alan Burnett - Head of Haematology Department of Medical Genetics, Cardiff, Wales )

Advances in multiple myeloma from ASH 2012

Prof Thierry Facon - Centre Hospitalier Universitaire, France

Advances in multiple myeloma from ASH 2012 ( Prof Thierry Facon - Centre Hospitalier Universitaire, France )

Expert overview of hot news in lymphoma from ASH 2012 (2/2)

Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger

Expert overview of hot news in lymphoma from ASH 2012 (2/2) ( Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger )

Expert overview of hot news in lymphoma from ASH 2012 (1/2)

Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger

Expert overview of hot news in lymphoma from ASH 2012 (1/2) ( Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger )

Advances in treatments for haematologic malignancies from the Sarah Cannon...

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (5/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )

Advances in treatments for haematologic malignancies from the Sarah Cannon...

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (4/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )

Advances in treatments for haematologic malignancies from the Sarah Cannon...

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (3/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )

Advances in treatments for haematologic malignancies from the Sarah Cannon...

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (2/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )

Advances in treatments for haematologic malignancies from the Sarah Cannon...

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (1/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )

More from ecancer